Live Breaking News & Updates on Hoc Analyses

Stay updated with breaking news from Hoc analyses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Text Messages With Financial Incentives for Men With Obesity

This randomized clinical trial assesses whether text messaging combined with financial incentives or text messages alone could help men with obesity lose ....

United Kingdom , City Of , Glasgow City , Pat Hoddinott , Health Economics Research Unit , National Institute For Health Research , National Institute Of Health , Health Technology Assessment , Health Action Process , School For Primary Care Research Funding , United Kingdom Office For National Statistics , Stirling University , Scientist Office , Scotland Research Ethics Committee , National Research Scotland Primary Care Network , Office For National Statistics , Research Unit , Scientist Office Of The Scottish Government Health , Health Professions Research Unit , Australian Heart Foundation , Development Division Of The Public Health Agency , Health Improvement , Health Services Research Unit , Public Health Research , National Institute For Health , Department Of Health ,

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial | Coronavirus (COVID-19) | JAMA

This randomized clinical trial compares the effects of 3 doses of bamlanivimab monotherapy (700 vs 2800 vs 7000 mg) vs combination bamlanivimab and etesevimab v ....

United States , Eteläuomen Läi , Junshi Biosciences , Bristol Myers Squibb , Danielm Skovronsky , Eli Lilly , Monte Carlo , Van Naarden , David Mcilwain , Abcellera Biologics , Drug Administration , Institute Inc , World Health Organization , Infectious Diseases Vaccine Research Center , Gilead Sciences , National Institute Of Allergy , Emergency Use , North America , Blocking Viral Attachment , Cell Entry , International Conference , Harmonization Guidelines , Good Clinical Practice , Secondary Outcomes , Enterprise Guide , Clinical Characteristics ,

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial | JAMA

This randomized trial assesses the comparative effectiveness of direct oral anticoagulants vs low-molecular-weight heparin on rate of 6-month recurrence of veno ....

Memorial Sloan Kettering Cancer Center , New York , United States , Genentech Roche , Quinn Johnston , Astellas Pharma , Deborah Schrag , Alliance Foundation Trials , Covington Burling , Blood Institute , Bristol Myers Squibb , Alliance For Clinical Trials In Oncology , Outcomes Research Institute , Drug Administration , National Institutes Of Health , Or Foundation , Item Short Form Health Survey , National Heart , American Cancer Society , Group Information , Health Services Advisory Group , American Society Of Clinical Oncology , Between December , Cancer Related , Clinical Trials , Trial Procedures ,

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial | Infectious Diseases | JAMA

This open-label randomized trial compares the effect of remdesivir (5 or 10 days) vs standard care on clinical status 11 days after treatment initiation among p ....

United States , Eteläuomen Läi , Soriano Viladomiu , Le Turnier , Glaxosmithkline Vii , Bristol Meyers Squibb , Dianam Brainard , Sanyal Bio , Group Information , European Medicines Agency , Boehringer Ingelheim , Laboratory Monitoring , European Medicines Agency For Europe , Institute Inc , National Institute Of Allergy , Drug Administration For The United States , Novo Nordisk , Gilead Sciences , Virginia Commonwealth University , Drug Administration , Emergency Use Authorization , Clinical Practice , Microsoft Excel , Hoc Analyses , End Point , Efficacy End Points ,

Neurocrine Biosciences Presents Data on Treatment of Patients with Congenital Adrenal Hyperplasia at ECE 2023

/PRNewswire/ Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced that it will present new. ....

United Kingdom , Northern Ireland , Neurocrine Biosciences , Eiryw Roberts , Prnewswire Neurocrine Biosciences Inc , Diurnal Ltd , European Commission , Healthcare Products Regulatory Agency , Regulatory Agency , Diurnal Group , European Commission For The Economic Area , European Congress , Drug Administration , Neurocrine Biosciences Inc , Post Hoc Analyses , Androgen Reduction Across , Broad Range , Hoc Analyses , Reduced Androgen Levels Compared , Immediate Release Hydrocortisone , European Economic Area , United Kingdom Medicines , Crinecerfont Treatment , Classic Congenital Adrenal Hyperplasia , Elevated Baseline Hormone Levels , Not Glucocorticoid Dose ,